Cargando…

HPV transcript expression affects cervical cancer response to chemoradiation

Persistent HPV infection is causative for the majority of cervical cancer cases; however, current guidelines do not require HPV testing for newly diagnosed cervical cancer. Using an institutional cohort of 88 patients with cervical cancer treated uniformly with standard-of-care chemoradiation treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz, Fiona J., Inkman, Matthew, Rashmi, Ramachandran, Muhammad, Naoshad, Gabriel, Nishanth, Miller, Christopher A., McLellan, Michael D., Goldstein, Michael, Markovina, Stephanie, Grigsby, Perry W., Zhang, Jin, Schwarz, Julie K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409981/ https://www.ncbi.nlm.nih.gov/pubmed/34255749 http://dx.doi.org/10.1172/jci.insight.138734

Ejemplares similares

Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas
por: Ruiz, Fiona J., et al.
Publicado: (2021)

Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer
por: Grigsby, Perry, et al.
Publicado: (2017)

HPV-EM: an accurate HPV detection and genotyping EM algorithm
por: Inkman, Matthew J., et al.
Publicado: (2020)

00003 Volumetric assessment of cervical cancer tumor volume during definitive chemoradiation and the risk of early distant metastasis
por: Pachigolla, Suvidya Lakshmi, et al.
Publicado: (2021)

SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
por: Wang, Songyan, et al.
Publicado: (2022)

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production
por: Chen, Liyun, et al.
Publicado: (2023)

AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
por: Rashmi, Ramachandran, et al.
Publicado: (2014)

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer
por: Lin, Alexander J., et al.
Publicado: (2018)

Drug Delivery Approaches for the Treatment of Cervical Cancer
por: Ordikhani, Farideh, et al.
Publicado: (2016)

The prognostic value of PET and PET/CT in cervical cancer
por: Grigsby, Perry W.
Publicado: (2008)

ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy
por: Javed, Shifa, et al.
Publicado: (2021)

Factors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical Cancer
por: Zaki, Mark, et al.
Publicado: (2016)

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation
por: Kanjanapan, Yada, et al.
Publicado: (2017)

Activation of miR-9 by human papillomavirus in cervical cancer
por: Liu, Weijun, et al.
Publicado: (2014)

Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer
por: Baxi, Shrujal S., et al.
Publicado: (2016)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer
por: Markovina, Stephanie
Publicado: (2021)

Oxidative stress in cervical cancer and its response to chemoradiation
por: Shah, Saiqa, et al.
Publicado: (2019)

Reducing prolonged chemoradiation treatment times for cervical cancer
por: Vitzthum, Lucas, et al.
Publicado: (2019)

Influence of chemoradiation on the immune microenvironment of cervical cancer patients
por: Herter, J. M., et al.
Publicado: (2022)

Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI
por: Hu, Yanle, et al.
Publicado: (2013)

Cervical necrosis after chemoradiation for cervical cancer: case series and literature review
por: Fawaz, Ziad Simon, et al.
Publicado: (2013)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Does HPV vaccination prevent cervical cancer?
por: Miller, Anthony B.
Publicado: (2013)

Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome
por: Brooks, Frank J, et al.
Publicado: (2011)

Educational Case: Cervical Neoplasia: HPV and Its Link to Cancer
por: Kim, Teresa, et al.
Publicado: (2018)

FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement
por: Brooks, Frank J, et al.
Publicado: (2013)

Perceptions of postnatal care: factors associated with primiparous mothers perceptions of postnatal communication and care
por: McLellan, Julie, et al.
Publicado: (2013)

Chemoradiation and the Role of Adjuvant Chemotherapy in Lymph Nodal–Metastatic Cervical Cancer
por: Ali, Nasir, et al.
Publicado: (2017)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Effect of Season and High Ambient Temperature on Activity Levels and Patterns of Grizzly Bears (Ursus arctos)
por: McLellan, Michelle L., et al.
Publicado: (2015)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Extracellular Vesicles in Cervical Cancer and HPV Infection
por: Acevedo-Sánchez, Víctor, et al.
Publicado: (2021)

Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis
por: Kim, Hee Seung, et al.
Publicado: (2013)

Chemoradiation for cervical cancer treatment portends high risk of pelvic floor dysfunction
por: Miguel, Taís Pereira, et al.
Publicado: (2020)

PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation
por: IJff, Marloes, et al.
Publicado: (2021)

The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review
por: Odiase, Otasowie, et al.
Publicado: (2021)

Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
por: Jamora, Kurl E., et al.
Publicado: (2022)

Respiratory syncytial virus entry and how to block it
por: Battles, Michael B., et al.
Publicado: (2019)

Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation
por: Conway, Jessica L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vv798c0j7a8djssbvc6te2v35v